Dr. Geetika Sabharwal has been honored with a 2025 Global Recognition Award for her sustained contributions to allergy and ...

By Pushkala Aripaka and Bhanvi Satija Jan 20 (Reuters) - Britain's GSK has agreed to buy RAPT Therapeutics for $2.2 billion, ...

GSK has agreed to acquire Rapt Therapeutics, a US-based biotech whose leading drug combats food allergies, in a deal that ...

The sizzle is the excitement about the hunt for the next big blockbuster, and the only one that anyone sees on the horizon is ...

Researchers at DTU have patented a new invention that uses naturally produced substances from bifidobacteria in the gut to help lower the risk of allergies and asthma. Allergies and asthma are ...

Allergies and asthma affect an increasing number of children worldwide, but now an international research group led by DTU ...

Asthma is one of the most prevalent chronic inflammatory respiratory diseases across the globe, with a significant increase ...

Tips for Dealing With, Spring Allergies. Allergies can lead to more than itchy eyes and a runny nose. They can also trigger ...

The likelihood for penicillin allergy delabeling was significantly reduced among Black and Asian patients vs. white patients, ...

Mold affects people in very different ways, from minor allergy symptoms to dangerous asthma attacks and infections, highlighting the need for awareness and prevention.

That price equates to an aggregate equity value of $2.2 billion, according to GSK, who added that the upfront investment net ...

Early Phase I data showed inhaled londamocitinib reduced airway inflammation in mild asthma with good tolerability. Learn ...